Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

Also called NCT03983551

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 101 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03983551
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03983551. Non-randomized; no masking; primary purpose treatment. Start 2016-03-01 (actual); primary completion 2018-02-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
Condition
Type 2 Diabetes Mellitus
Condition
Proteinuria
Intervention (Drug)
Dipeptidyl Peptidase 4 Inhibitor
Intervention (Drug)
Sulfonylurea
Lead sponsor
Changhua Christian Hospital (class: other)

Record details

Record id
cardio:ct-nct03983551
Content hash
d66add7ff56888e7b06c7033aa3f74fedefa0fcb276b9ee32390bd58c3b026e4